ISSN: 1369-6998

Journal Home

Journal Guideline

Journal of Medical Economics Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Medical Economics is a journal indexed in SJR in Health Policy with an H index of 56. It has a price of 4000 €. It has an SJR impact factor of 0,988 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,988.

Journal of Medical Economics focuses its scope in these topics and keywords: patients, united, burden, insulin, diabetes, study, costs, established, economics, disease, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Health Policy (Q1)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,988

SJR Impact factor

56

H Index

168

Total Docs (Last Year)

483

Total Docs (3 years)

6886

Total Refs

1318

Total Cites (3 years)

453

Citable Docs (3 years)

2.71

Cites/Doc (2 years)

40.99

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Planetary Health Q1
Health Affairs Q1
Alzheimer's and Dementia Q1
Implementation Science Q1
Milbank Quarterly Q1

Compare this journals

Aims and Scope

Best articles by citations

Understanding healthcare burden and treatment patterns among young adults with schizophrenia

Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis

The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine

Total cost comparison in relapsed/refractory multiple myeloma

Managing acute acetaminophen poisoning with oral versus intravenousN-acetylcysteine: a provider-perspective cost analysis

Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-typeRASmetastatic colorectal cancer

Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure

Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy

Determinants of private health insurance coverage among Mexican American men 2010-2013

Development and validation of a new instrument to evaluate the ease of use of patient-controlled analgesic modalities for postoperative patients

The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy

Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective

SHOW MORE ARTICLES

Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States

Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective

Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model

Pharmacoeconomics of ruxolitinib therapy in patients with myelofibrosis

How costly is non-adherence to infliximab in patients with Crohn's disease?

Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain

Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective

A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK

Short-term disability in solid tumor patients with bone metastases and skeletal-related events

Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy

Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies